Literature DB >> 16374677

Catheter closure of perimembranous/membranous ventricular septal defects using the Amplatzer occluder device.

B D Thanopoulos1.   

Abstract

Perimembranous ventricular septal effects (PMVSDs) are the most common congenital cardiac defects of clinical importance. During the last decade, transcatheter closure of PMVSDs has been attempted using various occluders with variable success. This article reviews the existing literature and our experience with transcatheter closure of PMVSDs with the new Amplatzer occluder device.

Entities:  

Mesh：

Year:  2005        PMID： 16374677     DOI： 10.1007/s00246-005-8647-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  13 in total

1.  Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations.

Authors:  Z M Hijazi; F Hakim; F Al-Fadley; J Abdelhamid; Q L Cao
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

2.  Description of ventricular septal defects--or how long is a piece of string?

Authors:  R H Anderson; A E Becker; M Tynan
Journal:  Int J Cardiol       Date:  1986-12       Impact factor: 4.164

3.  Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrella.

Authors:  M Vogel; M L Rigby; D Shore
Journal:  Pediatr Cardiol       Date:  1996 Nov-Dec       Impact factor: 1.655

4.  Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up.

Authors:  G S Kalra; P K Verma; A Dhall; S Singh; R Arora
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

5.  Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.

Authors:  B D Thanopoulos; G S Tsaousis; G N Konstadopoulou; A G Zarayelyan
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

6.  Preoperative transcatheter closure of congenital muscular ventricular septal defects.

Authors:  N D Bridges; S B Perry; J F Keane; S A Goldstein; V Mandell; J E Mayer; R A Jonas; A R Casteneda; J E Lock
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

7.  Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.

Authors:  John L Bass; G S Kalra; Ramesh Arora; Jozef Masura; Pavlo Gavora; Basil D Thanopoulos; William Torres; Horst Sievert; Mario Carminati; Gunther Fischer; Peter Ewert
Journal:  Catheter Cardiovasc Interv       Date:  2003-02       Impact factor: 2.692

8.  Primary transcatheter umbrella closure of perimembranous ventricular septal defect.

Authors:  M L Rigby; A N Redington
Journal:  Br Heart J       Date:  1994-10

9.  Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register.

Authors:  E B Sideris; K P Walsh; J L Haddad; C R Chen; S G Ren; H Kulkarni
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

10.  Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects.

Authors:  L Kidd; D J Driscoll; W M Gersony; C J Hayes; J F Keane; W M O'Fallon; D R Pieroni; R R Wolfe; W H Weidman
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690
View more
  1 in total

1.  Atrioventricular block after transcatheter closure of perimembranous ventricular septal defects.

Authors:  M A Walsh; J Bialkowski; M Szkutnik; M Pawelec-Wojtalik; W Bobkowski; K P Walsh
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.